PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

<p>The triple negative breast cancer (TNBC) paradox marks a major challenge in the treatment-decision making process. TNBC patients generally respond better to neoadjuvant chemotherapy compared to other breast cancer patients; however, they have a substantial higher risk of disease recurrence....

Full description

Saved in:
Bibliographic Details
Main Author: Ghaneya Al-Khadairi (14153274) (author)
Other Authors: Adviti Naik (673163) (author), Remy Thomas (702843) (author), Boshra Al-Sulaiti (14153277) (author), Shaheen Rizly (14153280) (author), Julie Decock (44558) (author)
Published: 2019
Subjects:
Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Oncology and carcinogenesis
PRAME
PReferentially Antigen expressed in Melanoma
Triple negative breast cancer
Migration
Invasion
Epithelial-to-mesenchymal transition
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items